Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on June 12, 2007. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

B -- Pathotyping of Highly Pathogenic Avian Influenza Virus and Reassortant Vaccine Candidate Virus in White Leghorn Chickens

Awarded
2007-Q-09637Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

N/A

Contract Value

$61,000

NAICS

541380 - Testing Laboratories and Services

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Presolicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts2 people available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Bonnie S KennedyContract Specialist
Jeff A MillerContract Specialist

Full Description

Show more
The Centers for Disease Control and Prevention (CDC), Coordinating Center for Infectious Diseases (CCID), National Center for Infectious & Repsiratory Diseases (NCIRD), Influenza Division (ID) will create reassortant viruses from Highly Pathogenic Avian Influenza (HPAI) wild type viruses as vaccine candidates. The CDC has a requirement for a study titled, Pathotyping of HPAI Virus A/Anhui/01/05 (H5N1) and Reassortant Vaccine Candidate A/Anhui01/2005(H5N1)-PR8-IBCDC-RG6 Virus in White Leghorn Chickens, to evaluate the pathogenicity of the reassortant avian influenza virus candidate versus the HPAI wild type virus by intravenous and intranasal pathotyping procedures to ensure that they have been rendered non-pathogenic. The intravenous and intranasal pathotyping procedures are prescribed by CDC for this evaluation. To qualify for this requirment a bidder must have the following capabilties relative to conducting research into the safety and performance of avian influenza technologies: a USDA approved Biosafety Level 3 or BSL3-Enhanced laboratory for working with HPAI; USDA and APHIS Select Agent Approvals for HPAI (facilites and individuals) and to perform Biological Testing Using Animals; experience in receipt and transport of influenza strains; IBC experience in AIV/HPAI protocol review; internal R&D vaccine studies using recombinant HA protein; AIV assay development; AIV reagent production; AIV molecular assays (RT-PCR). Performance of this study should begin no later than 22 June 2007. Based on the mandatory capabilities listed above and the government?s requirement for immediate performance, the CDC plans to award a noncompetitive contract action to Benchmark Biolabs, Inc; if, however, you believe you possess all of the mandatory capabilites and can meet the immediate start schedule, you may submit a bid, proposal, or quotation to the Contract Specialist no later than 19 June 2007 which will be considered by the CDC. To obtain an electronic copy of the SOW/CDC Protocol, request by email to contact@example.gov.

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS